CompletedEUCTR 2008-007482-23
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceBipolarity, DepressionHistorical research record
- Countries
- France, Czechia, Germany
- Sponsor
- Sunovion Pharmaceuticals, Inc.
CompletedEUCTR 2022-000461-41
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceDepressionHistorical research record
- Countries
- France, Bulgaria, Czechia, + 1 other
- Sponsor
- Janssen-Cilag International NV
CompletedEUCTR 2006-003560-62
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceSchizophreniaHistorical research record
- Countries
- France, Austria, Bulgaria, + 6 others
- Sponsor
- Janssen-Cilag International N.V.
CompletedEUCTR 2019-002992-33
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceDepressionHistorical research record
- Countries
- France, Belgium, Austria, + 11 others
- Sponsor
- Janssen-Cilag International NV
CompletedNCT00447278
Official study titleA Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents
This study has finished and is no longer accepting participants.
In FranceADHDMedication studyAges 6–16
- Countries
- France, United Kingdom, Belgium, + 6 others
- Sponsor
- Eli Lilly and Company
CompletedNCT04366973
Official study titleNew Care Pathways to Achieve HCV Elimination in the Community: Real-world Outcomes From HCV Infected Patients Treated in Addiction Centers in France
This study has finished and is no longer accepting participants.
In FranceAddictionObservational studyAges 18+
- Countries
- France
- Sponsor
- AbbVie
CompletedNCT05841030
Official study titleA Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI
This study has finished and is no longer accepting participants.
In FranceDepressionObservational studyAges 18–74
- Countries
- France, United States, Canada, + 8 others
- Sponsor
- Janssen Research & Development, LLC
TerminatedNCT01077791
Official study titleCognitive Remediation of the Ability to Infer Intention of Others in Schizophrenic Patients - A Controlled, Randomized Trial (Phase IIb)
This study ended early.
In FranceSchizophreniaBehavioural studyAges 18–57
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT00300846
Official study titleA Multicenter, Comparative, Randomized, Double-Blind, Placebo Controlled Study on the Effect on Weight of Adjunctive Treatment With Aripiprazole in Patients With Schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France, United Kingdom, Switzerland, + 9 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00261443
Official study titleEfficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy
This study has finished and is no longer accepting participants.
In FranceBipolarityMedication studyAges 18+
- Countries
- France, United States, Brazil, + 6 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00237939
What is this study about?This study evaluated the effectiveness of Aripiprazole for people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France, Belgium, Netherlands, + 2 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT05550532
What is this study about?This study evaluated the safety and effectiveness of Aticaprant for people with depression.
This study has finished and is no longer accepting participants.
In FranceDepressionMedication studyAges 18–74
- Countries
- France, United States, Canada, + 11 others
- Sponsor
- Janssen Research & Development, LLC